Nova Patents
AT246708T

Novel elastase inhibitors

Abstract

The present invention provides novel compounds of formula (I), hydrates, optical isomers and pharmaceutically acceptable salts thereof, wherein P3 is Ala, bAla, Leu, Ile, Val, Nva, Nlev or bVal; P2 is Pip, Aze, Pro (4-OH), Pro (4-OAc) or Pro (4-OBzl); R1 is the side chain of Ala, Leu, Ile, Val, Nva or bVal; and K is a group of the formula (f) wherein Z is a meanthene and B is a group of formula (j). The compounds of the invention are elastase inhibitors, particularly neutrophil elastase inhibitors and useful in medicine. ŕ

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

33 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
25279994United States of AmericaA
9505618United States of AmericaW

Members33

Family members, oldest first
DocumentOfficeKind
IL113940D0IsraelD0
CA2189527A1CanadaA1
WO9533763A1World Intellectual Property Organization (WIPO)A1
AU2470995AAustraliaA
ZA954430BSouth AfricaB
NO965097D0NorwayD0
HU9603312D0HungaryD0
FI964781AFinlandA
NO965097LNorwayL
CN1149877AChinaA
EP0804465A1European Patent Office (EPO)A1
JPH10500992AJapanA
HUT76926AHungaryA
AU689589B2AustraliaB2
MX9606030AMexicoA
NZ285565ANew ZealandA
IL113940AIsraelA
TW403762BTaiwan Province of ChinaB
CA2189527CCanadaC
HU221197B1HungaryB1
KR100347285B1Republic of KoreaB1
US2003096759A1United States of AmericaA1
EP0804465B1European Patent Office (EPO)B1
AT246708TThis recordAustriaT
ATE246708T1AustriaT1
DE69531459D1GermanyD1
DK0804465T3DenmarkT3
PT804465EPortugalE
SI0804465T1SloveniaT1
US6693072B2United States of AmericaB2
ES2199992T3SpainT3
DE69531459T2GermanyT2
JP3623799B2JapanB2